Wu Ting hadn't expected Deng Feifei to think so highly of him.
It was an offer that most people would find impossible to refuse.
Even Shen Siyuan felt the same way.
After all, the first phase of Wu Ting's project—the P3 predictive diagnostic and therapeutic method for chronic hepatitis B—couldn't bring any substantial profits to the Jin Pharmaceutical Group at its current stage.
The second phase was just a negative immunomodulation mechanism. The paper hadn't been published yet, and Li Ai's surgery couldn't be disclosed for certain reasons. Therefore, to the outside world, it was merely an unproven hypothesis for now.
As for the third and fourth phases of Wu Ting's project, they sounded impressive but were little more than castles in the air. Their feasibility was nowhere in sight.
Therefore, Deng Feifei had already made what she considered her most sincere offer.
If it weren't for his system, Wu Ting would have accepted without a moment's hesitation.
